Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 9, 2000 - Issue 8
Submit an article Journal homepage
152
Views
38
CrossRef citations to date
0
Altmetric
Review

Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces

Charles G Kelly Department of Oral Medicine and Pathology, Floor 28 Guy’s Tower, Guy’s Hospital, London SE1 9RT, UK. [email protected]
&
Justine S Younson Department of Oral Medicine and Pathology, Floor 28 Guy’s Tower, Guy’s Hospital, London SE1 9RT, UK. [email protected]
Pages 1711-1721 | Published online: 24 Feb 2005

Bibliography

  • RELMAN D, TUOMANEN E, FALKOW S, GOLENBOCK DT, SAUKKONEN K, WRIGHT SD: Recognition of a bacterial adhesin by an integrin: macrophage CR3 (am132, CD11b/CD18) binds filamentous hemagglutinin of Bordetella pertussis. Cell (1990) 61:1375–1382.
  • OLSEN A, WICK MJ, MORGELIN M, BJORCK L: Curli, fibrous surface proteins of Escherichia coli, interact with major histocompatibility complex class I molecules. Infect. Immun. (1998) 66:944–949.
  • ZAIDI TS, FLEISZIG SM, PRESTON MJ, GOLDBERG JB, PIERGB: Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion of Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. (1996) 37:976–986.
  • KANBE T, CUTLER JE: Evidence for adhesin activity inthe acid-stable moiety of the phosphomannoprotein cell wall complex of Candida albicans. Infect. Immun. (1994) 62:1662–1668.
  • ROBERTS JA, MARKLUND B, ILVER D et al.: TheGal(a1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc. Natl. Acad. Sci. USA (1994) 91:11889–11893.
  • •Together with [6], these studies are good examples of those that demonstrate the importance of adhesion for pathology.
  • CONNELL H, AGACE W, KLEMM P, SCHEMBRI M, MARILD, SVANBORG C: Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc. Natl. Acad. Sci. USA (1996) 93:9827–9832.
  • •See reference 5 for annotation.
  • GURUGE JL, FALK PG, LORENZ RG et al.: Epithelial alters the outcome of Helkobacter pylori infection. Proc. Nati Acad. Sci USA (1998)95:3925–3930.
  • ••Demonstrates the requirement for adhesion to producepathology using transgenic mice expressing Lewis b blood group antigen.
  • STEIN M, RAPPUOLI R, COVACCI A: Tyrosine phospho- of the Helkobacter pylori Cag antigen after cag-driven host cell translocation. Proc. Natl. Acad. Sci. USA (1997) 97:1263–1268.
  • •Provides the first step in a molecular explanation for pathology resulting from adhesion.
  • HAWKEY PM: Action against antibiotic resistance: no time to lose. Lancet (1998) 351:1298–1299.
  • IRVIN RT, BAUTISTA DL: Hope for the post-antibiotic era? Nature Biotechnoi (1999) 17:20.
  • LEHNER T, CALDWELL J, SMITH R: 'Deal passive immuni-zation by monoclonal antibodies against streptococcal antigen VII in the prevention of dental caries. Infect. Immun. (1985) 50:796–799.
  • ••Important study that demonstrates protection againstdisease in an animal model.
  • MA JK-C, HUNJAN M, SMITH R, LEHNER T: Specificity of antibodies in local passive immunization against Streptococcus mutans. Clin. Exp. Immunol. (1989) 77:331–337.
  • ••Demonstrates long-term protection against infection inhumans.
  • MA JK-C, HUNJAN M, SMITH R, KELLY C, LEHNER T: An investigation into the mechanisms of protection by local passive immunization with monoclonal antibodies against Streptococcus mutans. Infect. Immun. (1990) 58:3407–3414.
  • MA JK-C, HIKMAT BY, WYCOFF K et al.: Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans. Nature Med. (1998) 4:601–606.
  • ••First use of a plant-derived SIgA antibody in human therapy.
  • BOOTH V, ASHLEY FP, LEHNER T: Passive immunization monoclonal antibodies against Porphyromonas gingivalisin patients with periodontitis. Infect. Immun. (1996) 64:422–427.
  • •Further example of protection against infection in humans.
  • DE BERNARDIS F, BOCCANERA M, ADRIANI D, SPREGHINI E, SANTONI G, CASSONE A: Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun. (1997) 65:3399–3405.
  • HAN Y, MORRISON RP, CUTLER JE: A vaccine and antibodies that enhance mouse resistance to Candida albicans vaginal infection. Infect. Immun. (1998) 66:5771–5776.
  • •Demonstrates that intravaginal administration of antibody can protect against candidiasis.
  • HAN Y, RIESSELMAN MH, CUTLER JE: Protection against can didiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same ann o trio se as an IgM protective antibody. Infect. Immun. (2000) 68:1649–1654.
  • WATTS HJ, CHEAH FSH, HUBE B, SANGLARD D, GOW NAR: Altered adherence in strains of Candida albicans harbouring null mutations in secreted aspartic proteinase genes. FEMS Microbiol. Lett. (1998) 159:129–135.
  • LANGERMANN S, PALASZYNSKI S, BARNHART M et al.: of mucosal Escherichia coli infection by FimH-Adhesin-based systemic vaccination. Science (1997) 276:607–611.
  • ••Clear demonstration of the effectiveness of anti-adhesinantibody (anti-FimH) to clear infection at a site that is not normally colonised.
  • LANGERMANN S, MOLBY R, BURLEIN JE et al.: Vaccina- with FimH adhesin protects cynomolgus monkeys from colonization and infection by Escherichia coli. J. Infect. Dis. (2000) 81:774–778.
  • •Further demonstration of the effectiveness of antibodies in a non-human primate model.
  • KELLY CG, TODRYK S, KENDAL HL, MUNRO GH, LEHNERT: T-cell adhesion and B-cell epitopes of the cell surface Streptococcus mutans protein antigen I/II. Infect. Immun. (1995) 63:3649–3658.
  • KELLY CG, YOUNSON JS, HIKMAT BY et al: A syntheticpeptide adhesion epitope as a novel antimicrobial agent. Nature Biotechnol. (1999) 17:42–47.
  • •Describes protection against infection in humans following application of a synthetic peptide adhesin analogue.
  • IJAZ MK, NUR-E-KAMAL MSA, DAR FK et al.: Inhibition of infection in vitro and in vivo by a synthetic peptide from VP4. Vaccine (1998) 16:916–920.
  • •Demonstrates that an effective dose of synthetic peptide can be delivered to the intestine.
  • ZAIDI TS, PRESTON MJ, PIER GB: Inhibition of bacterialadherence to host tissue does not markedly affect disease in the murine model of Pseudomonas aerugi-nosa corneal infection. Infect. Immun. (1997) 65:1370–1376.
  • LEININGER E, ROBERTS M, KENIMER JG et al: Per tactin,an Ar g-Gly -Asp -containing Bordetella pertussis surface protein that promotes adherence of mammalian cells. Proc. Natl. Acad. Sci. USA (1991) 88:345–349.
  • TALAY SR, VALENTIN-WEIGAND P, JERLSTROM PG, TIMMIS KN, CHHATWAL GS: Fibr on ectin-binding protein of Streptococcus pyogenes: sequence of the binding domain involved in adherence of streptococci to epithelial cells. Infect. Immun. (1992) 60:3837–3844.
  • LEE KK, WONG WY, SHETH HB, HODGES RS, PARANCHYCH W, IRVIN RT: Use of synthetic peptides in characterization of microbial adhesins. Methods Enzymol. (1995) 253:115–131.
  • PUTNEY SD, BURKE PA: Improving protein therapeu-tics with sustained-release formulations. Nature Biotechnol. (1998) 16:153–157.
  • SLOAN-LANCASTER J, ALLEN PM: Altered peptideligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Ann. Rev. Immunol. (1996) 14:1–27.
  • ARONSON M, MEDALIA 0, SCHORI L, MIRELMAN D, SHARON N, OFEK I: Prevention of colonisation of the urinary tract of mice with Escherichia coliby blocking of bacterial adherence with methyl a-D- mannopyra-noside. J. Infect. Dis. (1979) 1 3 9:329–332.
  • •Early demonstration of prevention of infection with carbohydrate receptor analogues.
  • NEWBURG DS: Do the binding properties of oligosac- in milk protect human infants from gastroin-testinal bacteria? Nutr. (1997) 127:980S–984S.
  • KARLSSON K-A: Meaning and therapeutic potential of microbial recognition of host glycoconjugates. Mot. Microbiol. (1998) 29:1–11.
  • ZOPF D, ROTH S: Oligosaccharide anti-infective agents. Lancet (1996) 347:1017–1020.
  • •This, together with [35], is a good review of the use of oligosaccharide receptor analogues.
  • GREVE JM, DAVIS G, MEYER AM et al: The major human receptor is ICAM-1. Cell (1989) 56:839–847.
  • •See reference 34 for annotation.
  • STAUNTON DE, MERLUZZI VJ, ROTHLEIN R, BARTON R,MARLIN SD, SPRINGER TA: A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell (1989) 56:849–853.
  • MARLIN SD, STAUNTON DE, SPRINGER TA, STRATOWA C,SOMMERGRUBER W, MERLUZZI VJ: A soluble form of intercellular adhesion molecule-1 inhibits rhinovirus infection. Nature (1990) 344:70–72.
  • HUGUENEL HD, COHN D, DOCKUM DP et al: Prevention of rhinovirus infection in chimpanzees by soluble intercellular adhesion molecule-1. Am. J Respir. Crit. Care Med. (1997) 155:1206–1210.
  • TURNER RB, WECKER MT, POHL G et al.: Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection. JAMA (1999) 281: 1797-1804.
  • ••Human clinical trial demonstrating reduction in diseaseseverity (experimental infection with rhinovirus) due to treatment with a receptor analogue, soluble ICAM-1.
  • BARTHELSON R, MOBASSERI A, ZOPF D, SIMON P: Adherence of Streptococcus pneumoniae to respira-tory epithelial cells is inhibited by sialylated oligosac-charides. Infect. Iminun. (1998) 66:1439–1444.
  • IDANPÄÄN-HEIKKILA I, SIMON P, ZOPF D et al: Oligo sac-charides interfere with the establishment and progression of experimental pneumococcal pneumonia. J. Infect. Dis. (1997) 176:704–712.
  • •Shows in vivo protection against disease in an animal model with defined oligosaccharide receptor analogues.
  • BRYAN R, FELDMAN M, JAWETZ SC et al.: The effects of aerosolised dextran in a mouse model of Pseudo-monas aeruginosa pulmonary infection. J. Infect. Dis. (1999) 179:1449–1458.
  • MOURICOUT M, PETIT JM, CARIAS JR, JULIEN R: Glycoprotein glycans that inhibit adhesion of Escheri-chia coli mediated by K99 fimbriae: treatment of experimental colibacillosis. Infect. Immun. (1990) 58:98–106.
  • EVANS DG, KARJALAINEN TK, EVANS DJ, GRAHAM DY,LEE CH: Cloning, nucleotide sequence and expression of a gene encoding an adhesin subunit protein of pylori. J. Bacteriol (1993) 175:674–683.
  • MYSORE JV, WIGGINTON T, SIMON PM, ZOPF D, HEMAN-ACKAH LM, DUBOIS A: Treatment of Helko-barter pylori infection in rhesus monkeys using a antiadhesion compound. Gastroenterology (1999) 117:1316–1325.
  • •Partially successful attempt to treat established infection in an animal model.
  • COURTNEY HS, DALE JB, HASTY DL: Differential effects of the streptococcal fibronectin-binding protein, FBP54, on adhesion of group A streptococci to human buccal cells and Hep-2 tissue culture cells. Infect. Immun. (1996) 64:2415–2419.
  • VAN DER FLIER M, CHHUN N, WIZEMANN TM, MIN J, MCCARTHY JB, TUOMANEN El: Adherence of Strepto-coccus pneumoniae to immobilized fibronectin. Infect. Immun. (1995) 63:4317–4322.
  • WINTER G: Synthetic human antibodies and a strategy for protein engineering. FEBS Lett. (1998) 430:92–94.
  • KELLY CG, YOUNSON JS, HIKMAT BY et al.: A synthetic peptide adhesion epitope as a novel antimicrobial agent. Nature Biotechnol. (1999) 17:42–47.

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.